Lyrica (Pregabalin) Uses, Side Effects, Addiction

Lyrica, known by its generic name pregabalin, is a medication commonly prescribed to manage neuropathic pain, including diabetic nerve pain and nerve pain from a spinal cord injury, as well as epilepsy, fibromyalgia, and generalized anxiety disorder. Despite its benefits, Lyrica also poses significant risks of misuse and addiction, leading to serious health concerns. Understanding…

Luminal Addiction News

Table of Contents News And Facts:Luminal Use, Abuse, Addiction and Side Effects What Is Luminal Used For? Information On  Luminal Addiction Signs References and Resources News And Facts :Luminal Use, Abuse, Addiction and Side Effects There has been a considerable increase in prescription drug abuse and addiction during the past decade. Prescription drug misuse can…

Ludiomil (Maprotiline) Uses, Side Effects and More

Drugs such as Maprotiline (Ludiomil), a medication classified among medications called tetracyclic antidepressants, are pivotal in managing major depressive disorder and other related mental illnesses. These medications are used to enhance mood, reduce anxiety, and prevent suicidal tendencies among depressed patients. However, they also have their drawbacks, including the possibility of developing dependence and experiencing…

Kadian Addiction News

Table of Contents Kadian Use and Addiction News: FDA Regulations, Abuse and Effects References and Resources The FDA approved generic equivalents of the Kadian®, a product brand name, in November 2011. The drug is an extended-release morphine product manufactured by Actavis Elizabeth LLC. Even though the commercial introduction of a new generic formulation is perhaps…

Hydrocodone Addiction News

Table of Contents Classification of Hydrocodone as a Schedule II Drug Updates On Changes in Hydrocodone Prescribing Practices Hydrocodone Addiction News Reports On Signs of Success References and Resources Classification of Hydrocodone as a Schedule II Drug In October 2014, The DEA changed hydrocodone combination analgesics from Schedule III of the Controlled Substances Act to…

Horizant Addiction News

[fusion_builder_container hundred_percent=”no” hundred_percent_height=”no” hundred_percent_height_scroll=”no” hundred_percent_height_center_content=”yes” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” status=”published” publish_date=”” class=”” id=”” border_size=”” border_color=”” border_style=”solid” margin_top=”” margin_bottom=”” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” gradient_start_color=”” gradient_end_color=”” gradient_start_position=”0″ gradient_end_position=”100″ gradient_type=”linear” radial_direction=”center center” linear_angle=”180″ background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ background_blend_mode=”none” video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” video_preview_image=”” filter_hue=”0″ filter_saturation=”100″ filter_brightness=”100″ filter_contrast=”100″ filter_invert=”0″ filter_sepia=”0″ filter_opacity=”100″ filter_blur=”0″…

Doral Use and Addiction News

Table of Contents The FDA and OPDP Warns Galt Pharmaceuticals LLC about Doral Marketing Practices References and Resources The FDA and OPDP Warns Galt Pharmaceuticals LLC about Doral Marketing Practices The US Food and Drug Administration (FDA), and the Office of Prescription Drug Promotion (OPDP) sent a Warning Letter to Galt Pharmaceuticals LLC concerning its…

Illicit Drugs News: Abuse and Addiction

New research published in the Nature journal Scientific Reports investigated Ohio Health Department records from 2010 to 2017. They observed that white men between the ages of 30 and 39 were most at risk of lethal overdoses. The epidemic disproportionately affects white men over white women in all age categories, the study found.The study found…

Hysingla ER Abuse and Addiction – Latest News

The FDA Approves Abuse-Deterrent Hydrocodone Pill The FDA has given the go-ahead to Hysingla ER (hydrocodone bitartrate, Purdue Pharma), an extended-release opioid analgesic to manage pain severe enough to require long-term, daily, around-the-clock opioid treatment and for which alternative treatment options are inadequate around-the-clock, long-term. Hysingla ER has qualities that are expected to reduce, but…

Hydromorphone Hydrochloride Abuse and Addiction – Latest News

Table of Contents Hydromorphone Addiction News Hydromorphone Hydrochloride Addiction Reports On Licit Uses of Hydromorphone Reports On Illicit Uses of Hydromorphone Hcl Hydromorphone HCL News Today: Illicit Distribution Hydromorphone is a powerful Schedule II opioid analgesic drug whose abuse has been a persistent problem in the United States. It is advertised as injectable ampules, multiple-dose…